Loading clinical trials...
Loading clinical trials...
The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine tablets, 7.5 mg, to SALAGEN® Tablets, 7.5 mg (MGI) under fed conditions using a single-dose, randomized, 2-trea...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Roxane Laboratories
NCT05871580 · Burning Mouth Syndrome, Quality of Life, and more
NCT06258603 · Pneumonia, Mechanical Ventilation Complication, and more
NCT04914208 · Dry Mouth, Halitosis
NCT06240806 · Dry Mouth, Salivary Gland Diseases
NCT05506137 · Xerostomia, Dry Mouth
CEDRA Clinical Research, LLC
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions